NEW YORK, December 5, 2016 /PRNewswire/ --
ChineseInvestors.com (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors in both the U.S. and China, today announced that it has entered into a new strategic alliance framework agreement with Shenzhen Yuanrong PE Capital ("Yuanrong"), a private capital firm based in China. Under the framework agreement, CIIX and Yuanrong will engage together in raising seed capital from mainland Chinese investors with the use of proceeds going to locating and funding select propitious investment opportunities in the new emerging industry of medical and recreational cannabis.
This new strategic alliance will target two types of enterprises. The first category includes Chinese manufacturers that export products to the US, such as companies focusing on soil-free indoor gardening, energy-saving LEDs, greenhouse engineering design and greenhouse hardware. CIIX and Yuanrong will provide the companies with the individual and institutional funds raised in China, assistance in becoming publically-traded in the US market, and investor relations services to improve their visibility and profitability.
The second category includes companies that produce CBD oil, which is a natural, non-psychoactive concentrate extracted from cannabis. The use of CBD oil has been legalized in 50 states in the US, and it can also be exported to more than 40 countries including China. This concentrate can be widely used in nutrition supplements, skin care products, normal beverages and functional beverages and can be sold through either the traditional or direct sales method. Because China has a prospective consumer base of 1.5 billion people, whoever takes the first step to invest in these CBD oil manufacturers could have potentially towering profit opportunities.
Warren Wang, founder and CEO of CIIX, commented: "According to recent projections from Cowen & Co., one of the most preeminent boutique investment firms on Wall Street, the legal cannabis industry in the U.S. is expected to be worth $50 billion by 2026, expanding to more than eight times its current size. In addition, investment banks focusing on the cannabis industry have increased from one to five during the latest year."
Mr. Wang further remarked: "Many manufacturers in China want to participate in the cultivation of cannabis, and the recent strength of the US dollar exchange rate provides a further advantage to Chinese manufacturers. However, investors from mainland China have little access to information and insights about the US cannabis industry. Fortunately, ChineseInvestors.com has a clear lead in early research of the cannabis industry compared to our other peers. Our investment in The Medicine Man Denver, Inc. (MDCL) was a great success over the last three years. We are very confident our new strategic alliance with Yuanrong will provide Chinese individuals and institutional investors with the researched news in 2017."
About ChineseInvestors.com (OTCQB: CIIX):
ChineseInvestors.com, Inc. ('CIIX'), founded in 1999 endeavors to be an innovative company; providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified), (b) support services to our various partners, (c) consultative services to smaller private companies considering becoming a public company, (d) advertising and public relation related support services, and (e) other services we may identify having the potential to create value or partnership opportunity with our existing services.
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real time Company updates: https://twitter.com/ChineseFNEnglsh
Facebook Like us to receive live feeds: https://www.facebook.com/Chinesefncom
Add us on WeChat at: Chinesefn or download iPhone iOS App: Chinesefn.
14 Wall Street 20th Floor
New York, NY 10005
Office Tel: +1-800-958-8561
SOURCE ChineseInvestors.com, Inc